A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Fomivirsen sodium

Trial Locations (17)

10016

New York Univ Med Ctr, New York

10028

Vitreo - Retinal Consultants, New York

20006

Dr Alan Palestine, Washington D.C.

27710

Duke Univ, Durham

28204

Charlotte Eye Ear Nose & Throat Association, Charlotte

30327

Georgia Retina, Atlanta

33060

Dr Julio Perez, Fort Lauderdale

46202

Indiana Univ Med Ctr, Indianapolis

60610

Chicago Ctr for Clinical Research, Chicago

60612

Univ of Illinois, Chicago

77030

Baylor College of Medicine, Houston

90017

Retina - Vitreous Associates Med Group, Los Angeles

94110

Univ of California San Francisco / SF Gen Hosp, San Francisco

94115

Dr Jacob Lalezari, San Francisco

98104

Novum Inc, Seattle

191021192

Hahnemann Univ Hosp, Philadelphia

911052536

Community Eye Med Group, Pasadena

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY

NCT00002187 - A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis | Biotech Hunter | Biotech Hunter